Promising early results from a clinical trial at the Mayo Clinic out this week suggest that a modified version of the measles virus can be used to target cancer cells and put the condition into remission. Researchers intravenously delivered 10,000 times the typical dosage of measles vaccine to two women, 49- and 65-years-old, who had […]
Category CA TechnologiesTech
0 Comments
Latest Comments